Sign In
Buy YI
$4.29
+0.590 (+15.95%)
At Close: Jun 23, 2026
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow
12:10am, Monday, 13'th Nov 2023
SHANGHAI , Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
111, Inc. (YI) Q2 2023 Earnings Call Transcript
04:35pm, Thursday, 24'th Aug 2023
111, Inc. (NASDAQ:YI ) Q2 2023 Earnings Conference Call August 24, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman, and Chief Execut
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
02:00am, Thursday, 24'th Aug 2023
SHANGHAI , Aug. 24, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow
05:59am, Monday, 31'st Jul 2023
SHANGHAI , July 31, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
111, Inc. Turns Profitable
02:50pm, Monday, 10'th Jul 2023
The Covid lockdown headwinds could only temporarily dent the relentless progress the company is making, growing revenue, expanding gross margin, and producing substantial operating leverage. We can't
111, Inc. Announces First Quarter 2023 Unaudited Financial Results
01:22am, Thursday, 15'th Jun 2023
SHANGHAI, June 15, 2023 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with med
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
02:05am, Thursday, 25'th May 2023
SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, the European Hemato
2seventy bio Announces Additional Data from KarMMa Studies of Abecma (idecabtagene vicleucel) at ASCO 2023 and EHA 2023
12:37pm, Thursday, 11'th May 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT) today announced the presentation of four abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place
MediaAlpha Announces First Quarter 2023 Financial Results
04:05pm, Thursday, 04'th May 2023
LOS ANGELES--(BUSINESS WIRE)--MediaAlpha, Inc. (NYSE: MAX) today announced its financial results for the first quarter ended March 31, 2023. “We started the year with a good first quarter, as the an
Global Smart Media Conference Macau Summit Was Held, Jian Mao: Bringing Film Back to Where ChatGPT Can't Calculate
01:28pm, Tuesday, 02'nd May 2023
LOS ANGELES--(BUSINESS WIRE)--Since the end of last year, the emergence of artificial intelligence ChatGPT has caused widespread concern around the world. Recently, the Global Smart Media Conference M
111, Inc. (YI) Q4 2022 Earnings Call Transcript
01:15am, Friday, 24'th Mar 2023
111, Inc. (NASDAQ:YI ) Q4 2022 Earnings Conference Call March 23, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executiv
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow
02:35am, Thursday, 02'nd Mar 2023
SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a
111, Inc.: Privatization With An Interesting Twist
06:23am, Thursday, 15'th Dec 2022
111, Inc. has received a non-binding proposal to be acquired by a consortium led by the company's founders at $3.66/ADS. YI share price has recently soared, jumping to as much as 9% above the offer an
111, Inc. (YI) Q3 2022 Earnings Call Transcript
01:19pm, Thursday, 01'st Dec 2022
111, Inc. (NASDAQ:YI ) Q3 2022 Earnings Conference Call December 1, 2022 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Execut
